As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for C-19 treatment, at Rs 11,995 per dose. Reportedly, the company has commenced dispatching the drug which can reportedly reduce oxygen support in C-19 patients.
The Drug Controller General of India (DCGI) gave emergency authorisation for restricted use to Virafin, a single-use therapy, on April 23.
Technically known as Pegylated Interferon alpha-2b, it is used to treat moderate infection of C-19. The company has said, “91.15 per cent of patients treated with PegIFN were RT-PCR negative by day 7.”
Also read:
Govt to amend notification to allow import of oxytocin API to…
Medicine labels in Hindi along with English: DTAB dismisses proposal
Bharat Biotech begins direct supply of COVAXIN to 14 states
Vivimed Labs gets DGHS nod to Mfr Favipiravir tablets in India
Platform for Nurses, Healthcare Staff, Lab Technicians
Pharma companies are now essential services
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
